SEC Form 4 · accession 0000932440-16-000397
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jay Moorin
Director · 10% Owner
Alain Schreiber
Director · 10% Owner
ProQuest Management LLC
10% Owner
ProQuest Investments IV, L.P.
10% Owner
ProQuest Associates IV LLC
10% Owner
Period of report
May 20, 2016
Accepted (ET)
May 24, 2016 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | May 20, 2016 | J | 4,770,828 | — | D | 4,770,828 | I | By ProQuest Investments IV, L.P. |
| Common Stock $0,001 par valueF2 | May 20, 2016 | J | 9,360 | — | D | 9,360 | I | By ProQuest Financial LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by ProQuest Investments IV, L.P. ("Investments IV"), which ProQuest Financial LLC manages pursuant to a management agreement that was assigned from ProQuest Management LLC ("ProQuest Management") to ProQuest Financial LLC ("ProQuest Financial") in connection with an internal reorganization. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
- F2The shares were transferred from ProQuest Management to ProQuest Financial in connection with an internal reorganization. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities